Shirng-Wern Tsaih
7PUBLICATIONS
51CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Apr 03, 2026
Single-cell transcriptomics reveals FXR1 as an actionable target for siRNA therapy in ovarian cancer.Jasmine George, Xiaolong Ma, Ishaque Pulikkal Kadamberi
|Dec 05, 2024
Rearrangements of viral and human genomes at human papillomavirus integration events and their allele-specific impacts on cancer genome regulation.Vanessa L Porter, Michelle Ng, Kieran O'Neill
|Jun 05, 2024
Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer.Anjali Geethadevi, Zhiqiang Ku, Shirng-Wern Tsaih
|Apr 11, 2023
HLA antibodies in fetal and neonatal alloimmune thrombocytopenia.Zachary A Colvin, Jennifer Schiller, Shirng-Wern Tsaih
|Sep 15, 2021
NSG-Pro mouse model for uncovering resistance mechanisms and unique vulnerabilities in human luminal breast cancers.Yunguang Sun, Ning Yang, Fransiscus E Utama
|Oct 22, 2020
Peritoneal Spread of Ovarian Cancer Harbors Therapeutic Vulnerabilities Regulated by FOXM1 and EGFR/ERBB2 Signaling.Deepak Parashar, Bindu Nair, Anjali Geethadevi
Pageof 2
Frequent Collaborators
2 joint publications
Michael J Flister
2 joint publications
Deepak Parashar
2 joint publications
Bindu Nair
2 joint publications
Anjali Geethadevi
2 joint publications
Pradeep Chaluvally-Raghavan
2 joint publications
Janet S Rader
2 joint publications
Sunila Pradeep
1 joint publications
Sridhar Rao
1 joint publications
Subramaniam Malarkannan
1 joint publications
Chien-Wei Lin
